-
1دورية أكاديمية
المؤلفون: Seiwert, TY, Fayette, J, Cupissol, D, del Campo, JM, Clement, PM, Hitt, R, Degardin, M, Zhang, W, Blackman, A, Ehrnrooth, E, Cohen, EEW
المصدر: Annals of Oncology. 25(9)
مصطلحات موضوعية: Clinical Research, Clinical Trials and Supportive Activities, Cancer, Rare Diseases, Dental/Oral and Craniofacial Disease, 6.2 Cellular and gene therapies, 6.1 Pharmaceuticals, Evaluation of treatments and therapeutic interventions, Adult, Afatinib, Aged, Aged, 80 and over, Antibodies, Monoclonal, Humanized, Antineoplastic Agents, Carcinoma, Squamous Cell, Cetuximab, ErbB Receptors, Female, Head and Neck Neoplasms, Humans, Male, Middle Aged, Quinazolines, Receptor, ErbB-2, Squamous Cell Carcinoma of Head and Neck, Treatment Outcome, Young Adult, afatinib, cetuximab, recurrent HNSCC, metastatic HNSCC, EGFR inhibitor therapy, Receptor, erbB-2, Oncology and Carcinogenesis, Oncology & Carcinogenesis
وصف الملف: application/pdf
الوصول الحر: https://escholarship.org/uc/item/8qg7z19jTest
-
2دورية أكاديمية
المؤلفون: Seiwert, T Y, Fayette, J, Cupissol, D, Del Campo, J M, Clement, Paul, Hitt, R, Degardin, M, Zhang, W, Blackman, A, Ehrnrooth, E, Cohen, E E W
مصطلحات موضوعية: Adult, Aged, 80 and over, Antibodies, Monoclonal, Humanized, Antineoplastic Agents, Carcinoma, Squamous Cell, Cetuximab, Female, Head and Neck Neoplasms, Humans, Male, Middle Aged, Quinazolines, Receptor, Epidermal Growth Factor, ErbB-2, Treatment Outcome, Young Adult
وصف الملف: 315518 bytes; application/pdf
العلاقة: Annals of Oncology vol:25 issue:9 pages:1813-20; https://lirias.kuleuven.be/handle/123456789/602584Test; https://lirias.kuleuven.be/bitstream/123456789/602584/1//2014+AOO+A+randomized,+phase+II+study+of+afatinib+vs+cetuximab.pdfTest
الإتاحة: https://lirias.kuleuven.be/handle/123456789/602584Test
https://lirias.kuleuven.be/bitstream/123456789/602584/1//2014+AOO+A+randomized,+phase+II+study+of+afatinib+vs+cetuximab.pdfTest